Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TriAltus Bioscience has commercialized its proprietary CLīM™ protein purification system. The technology enables single-step purification of recombinant proteins with high yield, purity, and activity. It has been adopted by leading biotech companies and academic labs for enzyme production and was used in COVID‑19 vaccine research.[6] The company continues to expand patent protection and strategic partnerships.[7]
No clinical results are reported as the company does not develop therapeutics.
Their products have demonstrated effectiveness in supporting preclinical through GMP transitions for customers.
During the COVID‑19 pandemic, their technology was used by cancer institutes to accelerate vaccine development efforts.[6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TriAltus Bioscience.